| Code | CSB-RA928719A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
CRADD, also known as RAIDD, serves as a critical adaptor protein in apoptotic signaling pathways, functioning as a bridge between death receptors and downstream caspases. This death domain-containing protein recruits caspase-2 to the PIDDosome complex, playing an essential role in DNA damage-induced apoptosis and cellular stress responses. Understanding CRADD's involvement in programmed cell death has significant implications for cancer biology, neurodegenerative disease research, and developmental studies.
This recombinant monoclonal antibody, generated from clone 5D11, offers the reproducibility and consistency that demanding research applications require. Because the antibody sequence is defined and production occurs in a controlled recombinant system, researchers can expect reliable performance across experiments and between lots, eliminating the variability often encountered with traditional hybridoma-derived antibodies. The rabbit host and affinity-chromatography purification ensure high specificity for human CRADD.
Validation across multiple platforms demonstrates this antibody's versatility in your experimental workflow. Western blot analysis confirms detection of CRADD at the expected 23 kDa molecular weight in U937, HEK293, and COLO205 cell lysates, with recommended dilutions ranging from 1:500 to 1:2000. Immunohistochemistry studies successfully detected CRADD in paraffin-embedded human glioma tissue sections, while immunofluorescence staining in Jurkat cells revealed clear cytoplasmic localization patterns. Flow cytometry validation using PC-3 cells further extends the antibody's utility for single-cell analysis applications.
Whether investigating apoptotic pathway regulation, characterizing death domain protein interactions, or exploring CRADD's role in tumor biology and therapeutic resistance mechanisms, this antibody provides a dependable tool for advancing your research into programmed cell death signaling.
There are currently no reviews for this product.